News | January 31, 2011

U.K. Launches Initiative to Promote Radiotherapy

January 31, 2011 – An oncology systems provider has launched The Year of Radiotherapy, an initiative to raise awareness of radiotherapy as a cost-effective, cutting-edge treatment that can help cure cancer. Oncology Systems Limited (OSL) launched the program in response to data from Cancer Research UK.

According to figures published by Cancer Research UK, only one in 10 people know that radiotherapy helps cure 40 percent of cancer patients. A report from the national charity estimates that only 38 percent of cancer patients in England are getting radiotherapy, although research shows that up to 50 percent might benefit.

"We need to dispel the myths about radiotherapy and associated side effects and make people more aware of the benefits of the latest treatments,” said Julie Mead, clinical director of OSL. “But we also need to make sure that these treatments are available across the country. The U.K. lags behind America and Europe in introducing the new, more targeted radiotherapy technology that is available. Rather than update and reinvest in technology that's essentially been around for the last 40 or so years, it's time we made sure that every cancer patient in the U.K. has access to the best treatment."

"There's no doubt that our survival rates have risen and our treatment has improved almost beyond recognition,” said Sir Mike Richards, who launched OSL’s latest TomoTherapy installation at Nottingham City Hospital. “Our aim is to match the best in the world. With the TomoTherapy machine there will be treatments that people from the East Midlands and beyond will be able to access for the first time. I'm sure people from other trusts will come here to look for ideas for future treatment."

OSL is the U.K. and Ireland's exclusive distributor of the helical TomoTherapy treatment machine, which provides precise, targeted, image guided intensity modulated radiotherapy. There are more than 300 installations of the machine worldwide, but just six hospitals using the technology in the U.K.

For more information: www.osl.uk.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
Videos | Radiation Oncology | November 06, 2018
Genomics can be used to assess a patient's radiosensitivity, which can be used to increase or decrease the radiation
150-Year-Old Drug Might Improve Radiation Therapy for Cancer
News | Radiation Therapy | November 02, 2018
November 2, 2018 — A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more
A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers. #ASTRO18 #ASTRO2018

A model of the new, compact, single-room Varian ProBeam 360 system. The system is an example of the trend in proton therapy toward single-room, smaller systems and away from multi-room treatment centers.

Feature | Proton Therapy | November 01, 2018 | Dave Fornell, Editor
A few of the big takeaways from the American Societ...